Sector News

Medtronic-Covidien merger imminent after Irish court’s OK

January 26, 2015
Life sciences
The Irish High Court has approved the $43 billion merger between Medtronic Inc. and Ireland’s Covidien, clearing the way for the deal to close later today.
 
Medtronic and Covidien announced the court’s decision this morning. They will combine in a new company called Medtronic plc that’s legally based in Dublin, though its management remains at Medtronic’s current headquarters in Fridley, Minn. The two companies’ shares will continue to trade normally today, with the new stock starting to trade Tuesday.
 
Shareholders of the two companies approved the deal earlier this month.
 
The medical-device giant announced in June it would buy Dublin-based medical-products manufacturer Covidien.
 
By Mark Reilly
 

comments closed

Related News

June 3, 2023

Sanofi’s frexalimab shows early potential in in Phase II multiple sclerosis trial

Life sciences

In 2017, Sanofi partnered with the Lebanon, New Hampshire-based ImmuNext to develop an antibody for autoimmune diseases like lupus and multiple sclerosis, which included giving Sanofi a worldwide license to develop frexalimab. The agreement involved milestone payments upto $500 million.

June 3, 2023

Lonza to acquire Synaffix to strengthen ADC development

Life sciences

Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company focused on the commercialisation of its clinical stage technology platform for the development of antibody-drug conjugates (ADCs).

June 3, 2023

BD taps Novartis, GSK alum Laura Boros to lead drug delivery device business

Life sciences

In its hunt for the new head of its pharmaceutical systems business—which makes syringes, self-injection systems and other drug delivery devices for 70% of the top 100 drugmakers in the world, according to the company—BD landed on a candidate with plenty of experience among that customer group.

How can we help you?

We're easy to reach